Кардиоваскулярные нарушения у реципиентов трансплантата почки

М. В. Смолякова, Н. П. Митьковская, О. В. Калачик УО «Белорусский государственный медицинский университет». УЗ «9-я городская клиническая больница г. Минска»

2015 №1 | В помощь практикующему врачу

Аннотация

Список литературы

Скачать полнотекстовую статью

Статья содержит данные об особенностях и частоте встречаемости кардиоваскулярных нарушений у реципиентов трансплантата почки в раннем и среднеотдаленном послеоперационном периоде. Отражает сочетанное влияние различных факторов риска у данной группы пациентов, таких как курение, артериальная гипертензия, избыточная масса тела, анемия, дислипидемия, гипергликемия, нарушение функции трансплантата, прием иммуносупрессивных препаратов.

Ключевые слова:

трансплантация почки, кардиоваскулярная патология, стенокардия, артериальная гипертензия, дислипидемия, анемия, uNGAL

Cardiovascular impairments in renal transplant recipients

Due to the rapid development and modernization of Transplantation in the Republic of Belarus, the question of cardiovascular risk in patients the transplant kidney recipients became very important. Cardiovascular mortality recipients with a functioning graft is recognized as one of the leading causes of inefficiencies in the kidney transplant in the late postoperative period. This article contains information about the features of cardiovascular diseases in renal transplant recipients in the early and mid-term postoperative period. It reflects the combined effect of various risk factors in this group of patients, such as smoking, hypertension, overweight, anemia, dyslipidemia, hyperglycemia, graft dysfunction, immunosuppressive drugs. It emphasizes the importance of monitoring of the state of the cardiovascular system and differentiated approach prevention and treatment of these patients.

Keywords

kidney transplantation, cardiovascular diseases, angina, hypertension, dyslipidemia, anemia, uNGAL

1. Kasiske, B., Chakkera H., Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. // J. Am Soc Nephrology. – 2000. – Vol. 11. – P. 1735–1743.
2. Van der Schaaf M. R., Hene R. J., Floor M. et al. Hypertension after renal transplantation // J. Hypertension. – 1995. – Vol. 25. – P. 77–81.
3. Wheeller, D., Baigent C. Cardiovascular risk factors in chronic renal failure. In: Cardiovascular disease in End-stage Renal Failure // J. Loscalzo, G. London. Oxford. – 2000. – P. 2–28.
4. Vanrenterghem, I. Anemia after kidney transplantation // Transplantation. – 2009. – Vol. 87 (9). – P. 1265–1267.
5. Schjelderup, P., Dahle D. O.,Holdaas H. et al. Anemia is a predictor of graft loss but not cardiovascular events and allcause mortality in renal transplant recipients: follow-up data from the ALERT study // Clin Transplant. – 2013. – Vol. 27(6). – P. 636–643.
6. Drueke, T. et al. Atherosclerosis and lipid disorders after renal transplantation // J. Kidney Int. – 1991. – Vol. 39. – P. 24–28.
7. Maltz, H., Balog D., Cheigh J. Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine // Ann Pharmacother. – 1999. – Vol. 33. – P. 1176–1179.
8. Feustel, P. J., Elbahloul O., Conti A. D., Gallichio M. H., Conti D. J. Early steroid withdrawal therapy in renal transplant recipients: A steroid-free sirolimus and cellcept-based calcineurin inhibitor-minimization protocol // Clin Transplant. – 2007. – Vol. 21. – P. 101–109.
9. Feustel, P. J., Elbahloul O., Conti A. D., Gallichio M. H., Conti D. J. Early steroid withdrawal therapy in renal transplant recipients: A steroid-free sirolimus and cellcept-based calcineurin inhibitor-minimization protocol // Clin Transplant. – 2007. – Vol. 21. – P. 101–109.
10. Mishra, J. et al. Kidney NGAL is a novel early marker of acute injury following transplantation // PediatrNephrol. – 2006. – Vol. 21. – P. 856–863.